15 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250715559714/en/Repare-Therapeutics-Enters-Exclusive-Worldwide-Licensing-Agreement-with-Debiopharm-for-Lunresertib
12 Dec 2024
// BUSINESSWIRE
10 Dec 2024
// BUSINESSWIRE
23 Oct 2024
// BUSINESSWIRE
06 Aug 2024
// BUSINESSWIRE
26 Jun 2024
// BUSINESSWIRE